Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Oxaliplatin × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 62 Stomach Neoplasms 53 Rectal Neoplasms 35 Colonic Neoplasms 28 Pancreatic Neoplasms 23 Esophageal Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 19 Adenocarcinoma 19 Neoplasms 17 Cholangiocarcinoma 15 Neoplasm Metastasis 12 Adenocarcinoma Of Esophagus 12 Carcinoma, Non-Small-Cell Lung 10 Ovarian Neoplasms 9 Biliary Tract Neoplasms 9 Gastrointestinal Neoplasms 8 Gallbladder Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Locally Advanced Rectal Cancer 5 Recurrence 4 Lymphoma 4 Esophageal Squamous Cell Carcinoma 4 Endometrial Neoplasms 4 Carcinoma 4 Bile Duct Neoplasms 4 Advanced Solid Tumors 4 Triple Negative Breast Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡